Joseph Yeboah to Coronary Vessels
This is a "connection" page, showing publications Joseph Yeboah has written about Coronary Vessels.
Connection Strength
2.455
-
Yeboah J. Lung Cancer Screening Eligible? Circulation. 2018 12 18; 138(25):2867-2868.
Score: 0.594
-
Yeboah J, Young R, McClelland RL, Delaney JC, Polonsky TS, Dawood FZ, Blaha MJ, Miedema MD, Sibley CT, Carr JJ, Burke GL, Goff DC, Psaty BM, Greenland P, Herrington DM. Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment. J Am Coll Cardiol. 2016 Jan 19; 67(2):139-147.
Score: 0.485
-
Arps K, Rifai MA, Blaha MJ, Michos ED, Nasir K, Yeboah J, Budoff MJ, Blumenthal RS, Bittencourt MS, McEvoy JW. Usefulness of Coronary Artery Calcium to Identify Adults of Sufficiently High Risk for Atherothrombotic Cardiovascular Events to Consider Low-Dose Rivaroxaban Thromboprophylaxis (from MESA). Am J Cardiol. 2019 10 15; 124(8):1198-1206.
Score: 0.155
-
Garg PK, Jorgensen NW, McClelland RL, Leigh JA, Greenland P, Blaha MJ, Yoon AJ, Wong ND, Yeboah J, Budoff MJ. Use of coronary artery calcium testing to improve coronary heart disease risk assessment in a lung cancer screening population: The Multi-Ethnic Study of Atherosclerosis (MESA). J Cardiovasc Comput Tomogr. 2018 Nov - Dec; 12(6):493-499.
Score: 0.146
-
Yeboah J. Road to the American Heart Association 2020 Impact Goals: The Metric for Monitoring Progress. Circ Cardiovasc Imaging. 2018 01; 11(1):e007385.
Score: 0.139
-
Yeboah J, Blaha MJ, Michos ED, Qureshi W, Miedema M, Flueckiger P, Rodriguez CJ, Szklo M, Bertoni AG. Adult Height, Prevalent Coronary Artery Calcium Score, and Incident Cardiovascular Disease Outcomes in a Multiethnic Cohort. Am J Epidemiol. 2017 Oct 15; 186(8):935-943.
Score: 0.137
-
Sharma K, Al Rifai M, Ahmed HM, Dardari Z, Silverman MG, Yeboah J, Nasir K, Sklo M, Yancy C, Russell SD, Blumenthal RS, Blaha MJ. Usefulness of Coronary Artery Calcium to Predict Heart Failure With Preserved Ejection Fraction in Men Versus Women (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol. 2017 Nov 15; 120(10):1847-1853.
Score: 0.135
-
McEvoy JW, Martin SS, Dardari ZA, Miedema MD, Sandfort V, Yeboah J, Budoff MJ, Goff DC, Psaty BM, Post WS, Nasir K, Blumenthal RS, Blaha MJ. Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy. Circulation. 2017 Jan 10; 135(2):153-165.
Score: 0.129
-
Flueckiger P, Qureshi W, Michos ED, Blaha M, Burke G, Sandfort V, Herrington D, Yeboah J. Guideline-based statin/lipid-lowering therapy eligibility for primary prevention and accuracy of coronary artery calcium and clinical cardiovascular events: The Multi-Ethnic Study of Atherosclerosis (MESA). Clin Cardiol. 2017 Mar; 40(3):163-169.
Score: 0.128
-
O'Neal WT, Efird JT, Dawood FZ, Yeboah J, Alonso A, Heckbert SR, Soliman EZ. Coronary artery calcium and risk of atrial fibrillation (from the multi-ethnic study of atherosclerosis). Am J Cardiol. 2014 Dec 01; 114(11):1707-12.
Score: 0.111
-
Yeboah J, Carr JJ, Terry JG, Ding J, Zeb I, Liu S, Nasir K, Post W, Blumenthal RS, Budoff MJ. Computed tomography-derived cardiovascular risk markers, incident cardiovascular events, and all-cause mortality in nondiabetics: the Multi-Ethnic Study of Atherosclerosis. Eur J Prev Cardiol. 2014 Oct; 21(10):1233-41.
Score: 0.101
-
Eckman DM, Stacey RB, Rowe R, D'Agostino R, Kock ND, Sane DC, Torti FM, Yeboah J, Workman S, Lane KS, Hundley WG. Weekly doxorubicin increases coronary arteriolar wall and adventitial thickness. PLoS One. 2013; 8(2):e57554.
Score: 0.099
-
Yeboah J, McClelland RL, Polonsky TS, Burke GL, Sibley CT, O'Leary D, Carr JJ, Goff DC, Greenland P, Herrington DM. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA. 2012 Aug 22; 308(8):788-95.
Score: 0.096